FLT3 Gene Mutations among Acute Myeloid Leukemia patients in Northeast Thailand

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20220928006

Enrollment

Registered

2022-09-28

Start date

2020-01-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Newly diagnosed acute myeloid leukemia patients FLT3-ITD, FLT3-TKD, Acute myeloid leukemia, newly-diagnosed AML

Interventions

all newly diagnosed AML patients

Diagnostic

Acute myeloid leukemia patients

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: all newly diagnosed AML patients between January 2020 and May 2021

Exclusion criteria

Exclusion criteria: N/A

Design outcomes

Primary

Measure	Time frame
FLT3-ITD and FLT3-TKD at the beginning of study PCR based method	—

Secondary

Measure	Time frame
N/A N/A N/A	—

Countries

Thailand

Contacts

Public ContactSupawadee Yamsri

Faculty of Associated Medical Sciences, Khon Kaen University

supawadee@kku.ac.th043202083

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026